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ABSTRACT
The synthesis and characterization of the organotin compounds [(n-C4H9)zSn(cys)] (1), [(C6Hs)2Sn(cys)]
(2), [(C6Hs)3Sn(Hcys)’(H20)] (3), {[(CH3)2Sn(Kcys)2]’2(H20)} (4), {[(n-C4Hg)zSn(Kcys)z]’2(H20)} (5) and
{[(C6Hs)zSn(Kcys)z].2(H20)} (6) (where H_cys L-cysteine) are reported. The compounds have been
characterized by elemental analysis and 1H-NMR, Uv-Vis, FT-IR and MOssbauer spectroscopic techniques.
Attempted recrystallization of (2) in DMSO/methanol 2:1 solution yielded after several days unexpectedly
the dimeric compound bis(tri-phenyltin)sulphide {[(C6Hs)aSn]2S} (7) which has been characterized by x-ray
analysis. The structure of the parent complex (2) as well as the mechanism of the decomposition of cysteine
are being further investigated. The in vitro anticancer activity of complexes (I)- (6), against human
leukemia (HL60), human liver (Bel7402), human stomach (BGC823) and human cervix epithelial human
carcinoma (Hela), nasopharyngeal carcinoma (KB) and lung cancer (PG) tumor cells, were evaluated.
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I. INTRODUCTION
The biological activity of organotin(IV) compounds is well known/1-3/. Most organotin(IV) compounds
are generally toxic /3/. The binding of organotins by thiol groups, on the other hand, is significant in
biological systems /4/. A great deal of work has been reported thus far, on the interaction of organotin
compounds with thiol-containing mercapto-amino acids such as cysteine and its derivatives/3, 5-14/. The
interpretation of the results however, was rather controversial. Thus, based on M6ssbauer spectroscopy
Barbieri et al. /6/proposed a penta-coordinate structure for the L-cysteinato(S-)-triorgano-tin(IV) hydrate
[R3Sn(Cys)(H20)] (R Me- or Et- group) /6, 8/. A penta-coordinate geometry around tin atom was also
proposed by Huger et al./10/for [Ph2Sn(Cys)]. The anti-leukemic activity of compound [Ph2Sn(Cys)] was
evaluated by Huber et al./8/and was found to be remarkable in relation to its low toxicity. A tetrahedral
arrangement around tin(IV) was proposed for [Ph3Sn(HCys)] by Hyams et al. /14/and Huger et al. /10/.
According to spectroscopic data Bamgboye et al. /7/ proposed a polymeric chain structure for [(Ph3Sn)2cys]
with penta-coordinated tin atom/7/, while a double anionic structure was proposed by Domazetis et al./13/
for the {[(Me)2Sn(OH)2(cys)]2} at high pH. The crystal structure of the ethyI-L-cyteinatoS,N-(chloro-
dimethyl) stannate(IV) [(Me)2Sn(CI)(SCH2CH(NH2) COOC2H5] /11/ was determined by X-ray analysis and
indicated S, N chelated coordination of the ethyl-ester of cysteine with the tin atom in a distorted trigonal
bibyramidal configuration.
Another demand for such studies raised from the potential pharmaceutical application of organotin
compounds/5, 15/. Today, a number of organotin (IV) derivatives are known to have an efficient anti-turnout
activity/15/. A comparison of the structures of the active and inactive compounds suggests that all active
compounds should conform to the following requirements: (i) to have available coordination positions
around Sn, (ii) to have a relatively stable ligand-Sn bond (e.g. Sn-N and Sn-S) with low hydrolytic
decomposition/5/.
The aim of the present work is the exploration of new synthetic routes for the synthesis of organotin(IV)
complexes with cysteine, the better characterization of the compounds formed and the evaluation of anti-
cancer activity of the complexes derived and characterized.
2. EXPERIMENTAL
Materials and Instruments:
All solvents used were reagent grade, while organotin chlorides (Aldrich), cysteine (Merck) were used
with no further purification. Elemental analysis for C, H, N, and S were carried out with a Carlo Erba EA
Model 1108. Infra-red spectra in the region of 4000-370 cm were obtained in KBr discs while far-infra-red
spectra in the region of 400-50 cm were obtained in polyethylene discs, with a Perkin-EImer Spectrum GX
FT-IR spectrometer. A Jasco Uv/Vis/NIR V 570 series spectrophotometer was used to obtain the electronic
absorption spectra.. The H-NMR spectra were recorded on a Bruker AC250 MHFT-NMR instrument in
CDCI. solutions. Chemical shifts i are given in ppm using TMS as an internal reference. The gsn
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MCssbauer spectra were collected at various sample temperatures, with a constant acceleration spectrometer
equipped with CaSnO3 source kept at room temperature.
Synthesis ofL-cysteinato-k2S, O-di-n-butyl-tin(IV), [(n-C4H9)2Sn(cys)]} (I)
Cysteine (H2cys) (0.121 g, 1.0 mmol) was treated with Na2CO3 (0.106 g, 1.0 mmo|) Na2CO in H20 (17
cm) followed by addition of a solution of di-butyltin(IV) dichloride [(n-CaH9)2SnCI2] (0.152 g, 0.5 mmo|) in
methanol (3 cm). Chloroform (20 cm) was then added to this solution and the resulting mixture was stirred
for 3 h. The organic layer was dried over Na2SO4 and filtered to yield a clear solution. Removal of solvent
yielded a white powder of compound (1). Yield 0.045 g (26%); m.p.- 208-210 C;. Elemental analysis,
found: C: 37.63; H: 6.76; N: 3.57, S: 8.96 %, calculated for CHz3NOzSSn: C: 37.53; H: 6.58; N: 3.98, S:
9.11%. IR (cml): 3240s, 2956vs, 2923vs, 2855s, 1641vs, 1545m, 1464m, 1429m, 1390s, 1322s, 1300,
1050m, 867m, 800w, 681m, 583m; 460s, 397m.
Synthesis ofL-cysteinato-k2S, O-diphenyl-tin(IV), [(C6Hs)2Sn(cys)]} (2):
Cysteine (H2cys) (0.243 g, 2 mmol) was treated with NazCO (0.212 g, 2 mmol) in H20 (17 cm)
followed by addition of a solution of di-pheny|tin(IV) dichloride [(C6Hs)2SnCI2] (0.344 g, mmol) in
methanol (3 cm). A white precipitate of (2) was formed immediately. Yield 0.08 g (20 %); m.p. 240-245
C;. Elemental analysis, found: C: 45.86; H: 3.89; N: 3.62, S: 8.35 %, calculated for CsHINO2SSn: C:
45.96; H: 3.85; N: 3.57, S: 8.18 %. IR (cm): 3240s, 2956vs, 2923vs, 2855s, 1641vs, 1545m, 1464m,
1429m, 1390s, 1322s, 1300m, 1050m, 867m, 800w, 681 m, 583m; 460s, 396m.
Attempted re-crystallisation of (2) in DMSO/methanol 2:1 solution yielded, after several days,
unexpectedly, the dimeric compound bis(tri-phenyltin)sulfide {[(C6H)3Sn]2S} (7)/16/.
Synthesis ofL-cysteinato(S-)-triphenyl-tin(IV) hydrate, [(C6Hs)3Sn(Hcys)(H20)]} (3):
Cysteine (H2cys) (0.121 g, mmol) was treated with NazCO (0.106 g, mmol in H20 (17 cm3) and a
solution of tri-phenyltin(|V) chloride [(C6H)zSnCI2] (0.385 g, mmol) in methanol (6 cm) was added. A
white precipitate of (3) was formed immediately. Yield 0.24 g (50 %); m.p. 224-228 C;. Elemental
analysis, found: C: 51.90; H: 4.46; N: 3.19, S: 6.38 %, calculated for C2H2NOSSn: C: 51.67; H: 4.74; N:
2.87, S: 6.57 %. IR (cm): 3426s, 3065m, 2925m, 2853s, 1637vs, 1429s, 1388s, 1340s, 1300m, 1074s,
728vs, 697vs, 540m; 45 m, 396m.
Synthesis of {[(CH3)2Sn(Kcys)2]"2(H20)} (4), {[(n-CuH9)2Sn(Kcys)2]"2(H20)} (:) and
{[(C,Hs)2Sn(Kcys)2].2(H20)I (6):
Cysteine (H2cys) (0.121 g, mmo|) in H20 (5 cm3) was treated with solution of KOH IN (2 cm3, 2
retool). The resulting solution was concentrated to a small volume, where upon a colorless oily product was
formed. The oil was then dissolved in methanol (10 ml) followed by addition of a solution of the appropriate
di-organotin(IV) dichloride (0.5 mmol), (0.109 g di-methyl(IV) dichloride, 0.152 g, di-butyltin(IV)
dichloride, 0.170 g di-phenyltin(IV) dichloride) in methanol (5 ml). The solution was stirred for h and a
white precipitate of KCI was formed. The mixture was then filtered off and the resulting clear solution was
concentrated to dryness in a rotary evaporator under vacuum to yield a white powdered product.
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{[(CH3)2Sn(Kcys)z].2(HzO)} (4): Yield 0.053 g; m.p. 178-185 C;. Elemental analysis, found: 18.91; H:
3.69; N: 5.65, S: 12.25 %, calculated for CH20KNO6SzSn: C: 19.17; H: 4.02; N: 5.59, S: 12.79 %. |R
(cm): 3447s, 2925m, 1637vs, 1499m, 1399m, 1341m,1298m, 1124m, 853m, 418s, 397m.
{[(n-C4Hg)zSn(OH)z(cys)]K} (5): Yield 0.057 g; m.p. 159-165 C;. Elemental analysis, found: C: 29.08;
H: 5.82; N: 4.22, S: 10.75 %, calculated for C4H32KzNzO6SSn: C: 28.73; H: 5.50; N: 4.79, S: 10.95 %. IR
(cm-): 3448s, 2957m, 2924m, 2854m, 1618vs, 1509m, 1459m, 1425m,1396m, 1341 m, 1293m, !41m,
1053m, 847m, 533m, 397m.
{[(C6H)zSn(OH)z(cys)2]K2} (6): Yield 0.06 g; m.p. 219-222 C;. Elemental analysis, found: C: 34.75;
H: 3.60; N: 4.67, S: 10.38 %, calculated for CH4N206S2Sn: C: 34.57; H: 3.86; N: 4.48, S: 10.25 %. |R
(cm-): 3435s, 2924m, 1625vs, 1509m, 1428m, 1388m, 1336m, 1310m, I112m, 852m, 732m, 697m;538m,
455m, 418m, 397m).
Biological test
Anticancer activity against Human leukemia (HL60), Human liver (Bel7402), Human stomach (BGC823)
and Human cervix epithelial human carcinoma (Hela), Nasopharyngeal Carcinoma (KB), Lung Cancer (PG)
tumor cells, in vitro was evaluated by using a system based on MTT. Tumor cells were grown in RPMII640
medium supplemented with 10% freshly inactivated fetal calf serum (FCS) and antibiotics from the cells
harvested from exponential phase were seeded equivalently onto a 96-well plate, the compounds studied
were added in a concentration gradient, and the final concentrations were maintained at 100, 10, 1, and 0.1
m, respectively. The plate was kept at 37 C in a humidified atmosphere of 5% CO2 and incubated for 48 h.
MTT solution was added to each well. After incubation for 4 h at 37 C, acid-isopropanol was added to all
wells. The measurements of absorbance of the solutions related to the number of living ceils were carried out
on a Bio-Rad Model 450 Microplate Reader at 570 nm.
Crystal structure ofbis(triphenyl-tin(IV))sulphide [[(C,H)3Sn]S} (7):
The crystal structure of compound (7), (C6H0SSn2) was solved with SHELXS97 [18] and refined by
full-matrix least-squares procedures on F. Data were collected on a KUMA KM4CCD four-circle
diffractometer/l 8/, with a CCD detector. (Compound (7): (C,H0SSn). MW 732.04, orthorhombic, space
group P222, a 9.8419(8) A, b 17.6680(13) A, c 18.4958(14), Z 4, V 3216.2(2) A, Z 4, T 293(2)
K, 9(caid)- 1.512 g cm’, lu 1.640 mm, Crystal size: 0.3 x 0.1 x 0.1 mm3, goodness-of-fit on F2-- I. 113,
Final R indices [|>2.5sigma(i)]; R 0.0501, wR2 0.0442).
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3. RESULTS AND DISCUSSION
General aspects
Compound (1) has been synthesized using a water/methanol/chloroform 17:3:20, solvent system while
compounds (2) and (3) were synthesized in a water/methanol 17:3 according to equation (1)
RnSnCl4.n + 2 H2Cys + (4-n) Na2CO3
RnSn(Hn.zCys) + 2 (4-n) NaCI + (4-n) H20 + (4-n) CO2 (eq 1.)
(where n--2 and R C4H9-(1), C6H5- (2) or n=3 and R: C6H5- (3)).
Compounds (4), (5), (6) have been synthesized in a water/methanol 7:10 solution, according to equation
(2)
R2SnCI2 + 2 H2Cys + 4 KOH {[RzSn (K Cys)2] 2(H20)} + 2 KCI + 2 H20 (eq. 2)
where R=CH3-(4), C4H9-(5), C6H5-(6)
The formulae of complexes synthesized were deduced from elemental analysis and spectroscopic data.
Complexes (1) (3) are soluble in DMSO, while complex (1)is also soluble in chloroform, dichloromethane
and acetone, (3) is soluble in methanol and acetone, while (4)-(5) are soluble in methanol.
Compound (3) was synthesized previously from {(C6Hs)3Sn(OH)} and L-cysteine in chloroform/water or
methanol/ether media by Huber et al./10/and Hyams et al. /14/. Huber et al./8, 10/have also, reported the
synthesis of {(C6Hs)zSn(cys)} (2) by reacting {(C6Hs)2Sn(OH)2} with cysteine in chloroform/water. The
interaction of L-cysteine with tri-phenyltin(IV)producing {bis-(triphenyltin)cysteine} {[(C6Hs)3Sn]2(Hcys)}
was also studied by Bamgboye et al./7/.
Attempted recrystallization of (2) in DMSO/methanol 2:1 solution yielded after several days the dimeric
compound bis(tri-phenyltin) sulphide {[(C6Hs)3Sn]2S} (7) which was characterized by x-ray analysis and
found identical to the one previously reported by Glidewell et al./16a/, Cox/16b/and D’yachenko/16c/. The
method of preparation of the crystal was different however. In addition Domazetis et al. /17/ detected
{[(C6Hs)3Sn]2S} by mass spectroscopic techniques.
The de-sulphuration reaction of cysteine is known to play a role in thiol catabolism in biological systems
/19/.
A possible mechanism of de-sulphuration of {(C6Hs)2Sn(cys)} (2) may be summarized below, knowing
that such compounds decompose slowly on standing, forming bis(tri-phenyltin) sulphide {[(C6Hs)3Sn]2S}
/17/. Cysteine was also detected by IR and mp in the precipitate.
(C6H5)2 Sn(cys)
DMSO MeOH
H20 ((C6Hs)3Sn)2 S + 2Sn + 2cystine + alanine
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Spectroscopy"
Infra-red: Characteristic frequencies in IR spectra of complexes (1)-(6) are listed in Table 1.
Table 1.
Characteristic vibration bands (cm!) in infra-red spectra of complexes or ligands
L-Cys
(2)
(3)
% NHa
3428
3166
3306
3240
3449
3269
3436
3052
v.(Cn) v (s-n) v,(COO-)
2994 2551 1575
2956 absent 1637
2919
2925
absent
absent
1611
1627
v(oo) v(C-S)
1395 691
v(Sn-S)
1390 681 397
659 396 1380
1388 672 395
v(Sn-O)
583
570
540
(4) 3447 2924 absent 1637 1399 675 397 528
(5) 3431 2949 absent 1618 1395 677 392 533
2924 (6) 374 1625 1388 3435
3042
589 538
ref
/13,
22/
v antisymmetric strain, 6. antisymmetric bend.
Both coordination and increase in the ionic character of the carboxylate group tend to reduce the
asymmetric v(O-C=O) frequency/12, 20-21/. The Vas(COO) is observed at 1575 cm in free cysteine/22/.
The corresponding Vas(COO) vibration in the spectra of complexes (1)-(3) shift to higher frequencies (Table
1) indicating coordination of cysteine through the carboxyl group to tin atom/10, 13/. The magnitudes of the
[Vas(COO) vs(COO)] (Av) separation in complexes (I)-(3) (Av=239+8) are comparable to those reported for
organotin derivatives of L-cysteine and L-cysteine ethyl ester/12, 13, 2 I/. The conclusions drawn above are
further supported by the presence in the IR spectra of a sharp band at 560+20 cm-, which was assigned to the
Sn-O stretching vibration/2 I/(Table 1). The organotin compounds (4)-(6) have carbonyl Vas(COO) vibration
at 1627+ 10 cm-. The band position of Av [Vas(COO) -vs(COO) =228+10] in the case of compounds (4)-(6)
indicate coordination of cysteine through the carboxyl group to tin atom as well/12, 13, 21/. The stretching
frequencies for NH2 group in the ir spectra of compounds (I)-(6) can help to distinguish coordinated from
free amino groups. The v(NH2) of the free amino group is observed at 3166cm in cysteine/13, 22/. The
assignment of the-NHz group has been made by deuterization of the samples using D20. The corresponding
v(NH2) vibrations of the organotin derivatives (I)-(6) remain at the same frequency indicating that
coordination through the amino group of cysteine to tin atoms does not take place. These conclusions are
further supported by the absence in the far-IR of a band assignable to v(Sn-N)/21/. The absence of v(S-H)
bands in the IR spectra of compounds (I)-(6) shows a coordination of sulfur to tin atom. The stretching
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frequency ofC-S bond in IR spectra of cysteine is observed at 691 cm-I/13, 22/. The corresponding vibration
v(C-S) of organotin derivatives (!)-(6) shifts to lower frequencies (Table 1) supporting the same conclusion.
119SFl MOssbauer spectra: Mssbauer parameters of compounds (!)-(6) are listed in Table 2, while the quality
of the 19Sn M6ssbauer spectrum of the compounds measured at 85K are shown in Figure 1.
Table 2
M0ssbauer parameters ofcompounds (1)-(6)
Compound 6 (mms-) AEq (mms-) Area % i (mms) AEq (mms-) Area%
1.25 2.77 68 l.Sl 2.94 32
2 1.32 2.86 71 1.21 2.65 29
3 1.31 1.44 78 1.27 2.96 22
4 1.62 2,75 42 1.16 2.82 58
5 1.42 1.77 37 1.41 3.02 63
1.42 2.40 45 1.15 2.35 55
The occurrence of two symmetric Lorentzian doublets in the spectra of compounds (1)-(6) show two
distinct coordination sites with tin/2, 23/. The values between the quadruple splitting resonances of the two
symmetric Lorentzian doublets in the spectrum of compound (3) (Table 2) differ significantly, allowing the
assignment of the environment around the tin atom/7/to be made. In the case of compound (3), a resonance
with smaller splitting (tin moiety with contribution of 80% in the sample) is similar to that in [(Ph3Sn)2Cys]
/7/ and is assigned to a tetrahedral [Ph3SnS] environment, while that with the higher splitting resonance
corresponds to the penta-coordinated Ph3Sn(Cys,S-)(OH2) environment /7/. For compound (5), the inner
doublet was assigned to the BuSn-S moiety while the outer doublet was assigned to the BuSn-O moiety/12/.
The quadruple splitting values (AEq) of complexes (I)-(6) are typical of organotin thiolate derivatives
/12/. The AEq values of compounds (I), (2), (4) and (6) are in the range of 2.35 to 3.02 mms-
showing
octahedral arrangement around tin(IV)/7, 14, 24/. The low values of the quadruple splitting parameter, AEq
(<1.77 mms-), in the case of complexes (3) and (5) are characteristic of a tetrahedral geometry around tin
/25/.
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Figure I. The 119Sn MOssbauer spectra ofcompounds (I)- (6).
lOO,O,
Velocity (minis) Velocity (mml$)
NMR spectra: Chemical shifts observed in H-NMR of L-cysteine and its compounds (1), (2), (4) and (5) are
listed in Table 3.
H-NMR spectrum of free cysteine in DMSO-d6 shows signals at 2.86 and 3.12 ppm for-CH2- and -CH-
protons respectively. The signal in H-NMR spectrum of complex (2) in DMSO-d6 at 2.91 ppm is assigned to
the -CH2- and -CH- protons of coordinated cysteine.
The corresponding resonance signals of-CH2- and-CH- groups in H-NMR of free cysteine in CD3OH
are observed at 3.10 and 4.02 ppm respectively; these are shifted to 2.94-2.98 ppm and 3.7 ppm respectively
in the case of (4) and at 2.89-2.98 ppm and 3.6 ppm in the case of complex (5), indicating coordination of
cysteine to tin(IV) atom.
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Table 3
1H NMR chemicals shifts of the compounds in ppm.
Compound Chemical Shifts of Organotin
Moiety
Shifts of L-cysteine
-CH2 -CH
CYSteine CD3OD 3. 0 4.02
Cysteine DMSO d6 2.86 3.12
(1) CDCI3 0.88-1.56 (n-C4H9-) 2.67-3.04 3.48
(2)DMSO-d6 7.25-7.88 (C6H5-) 2.91
(4) CD3OD 0.81 (CH3-) 2.94-2.96 3.7
(5) CD3OD 0.87-1.72 (n-C4H9-) 2.89-2.98 3.6
H-NMR spectrum of complex (I) in CDCl3 shows signals for the -CH2- and -CH- protons of cysteine at
2.67-3.04 and 3.48 ppm.
The 3C-NMR spectrum of free cysteine in DMSO-d6 shows signals at 169.86 ppm for the -COO and at
56.50 ppm, 26.12 ppm for the Ca and Cb atoms respectively. The 3C-NMR spectrum of the complex (1)
shows resonance signals at 174.34 ppm for the -COO and at 57.25, 31.14 ppm for the Ca and Cb atoms
respectively. The signals of the carboxylic-COO and Cb atoms have been shifted downfield by 4.5 and 5.0
ppm respectively towards the corresponding signals of free cysteine indicating the cysteinato-k2S,O
coordination mode in the case of complex (1). The signal at 57.25 ppm is attributed to the Ca atom of the
coordinated cysteine while four new signals also appear in the 3C-NMR spectrum of complex (I) at 28.33,
27.16 (J Sn-Ca’= 51 Hz), 23.25 and 14.54 ppm which are attributed to the Cb’, Ca’, Cc’ and Cd’ atoms of the
butyl group.
Biological tests: The in vitro anticancer activity of the complexes (1)- (6), against Human leukemia (HL60),
Human liver (Be17402), Human stomach (BGC823) and Human cervix epithelial human carcinoma (Hela),
Nasopharyngeal Carcinoma (KB), Lung Cancer (PG) tumor cells is shown in Table 4.
Results show that complexes (1), (2) and (5) exhibit high cell toxicity against Hela while complexes (1),
(3) and (6) show high cell toxicity against BGC. Cell toxicity at concentrations of 10 JM and the cells were
viable to less than 10 %. A further systematic investigation of the biological properties of these metal
compounds is recommended focusing on their mutual significance for tumor induction of neoplastic growth.
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Table 4
The in vitro anticancer activity of the complexes (1)- (6), against Human cervix epithelial human carcinoma
(Hela), Human stomach (BGC823), Human leukemia (HL60), Lung Cancer (PG), Human liver (Be17402)
and Nasopharyngeal Carcinoma (KB) tumor cells
Sample
()
(2)
(4)
(5)
(6)
()
Cell line
Hela
Hela
Hela
Hela
Hela
BGC
Concentration
(lttM)
0.1
1.0
10
100
0.1
1.0
10
100
0.1
1.0
10
100
0.1
1.0
10
0.1
1.0
10
100
Inhibition rate
(%)
-9.43
27.97
77.12
106.12
-16.73
0.54
92.70
95.62
17.66
15.17
14.24
64.37
-6.98
-7.93
8.37
-38.93
-38.91
71.98
96.14
0.1
1.0
10
I00
-2.80
34.20
67.61
84.38
Evaluation of
anti-cancer
activity in vitro.
+
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Table 4 (continued)
(3)
(4)
(6)
(5)
(5)
(5)
(5)
BGC
BGC
BGC
HL-60
PG
Bel-7402
KB
0.1
1.0
10
100
0.1
1.0
10
100
0.1
1.0
10
100
0.1
1.0
10
0.1
1.0
10
0.1
1.0
10
0.1
1.0
10
(+) Effect on tumor in vitro, (-) No effect on tumor in vitro.
-7.46
7.93
68.78
86.58
8.14
3.37
-1.57
30.24
-5.33
3.27
69.75
83.54
-3.54
4.73
37.14
12.71
13.57
27.18
5.91
1.92
25.32
8.19
23.3
65.03
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